These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 3066035)

  • 1. Hemodynamic consequences of supraventricular tachycardias and their antiarrhythmic treatment.
    Yusoff K; Tai YT; Campbell RW
    Z Kardiol; 1988; 77 Suppl 5():137-42. PubMed ID: 3066035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Catheter ablation in supraventricular tachycardia].
    Pitschner HF; Neuzner J
    Z Kardiol; 1996; 85 Suppl 6():45-60. PubMed ID: 9064982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical viewpoints of hemodynamics in cardiac arrhythmias and during anti-arrhythmia treatment].
    Thormann J
    Z Kardiol; 1988; 77 Suppl 5():121-36. PubMed ID: 3066034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Exogenous adenosine as an anti-arrhythmia agent].
    Tebbenjohanns J; Pfeiffer D; Schumacher B; Korte T; Jung W; Lüderitz B
    Z Kardiol; 1996; 85 Suppl 6():191-9. PubMed ID: 9064965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hemodynamics in ventricular arrhythmias and in their treatment].
    Lüderitz B; Manz M
    Z Kardiol; 1988; 77 Suppl 5():143-9. PubMed ID: 3066036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accessory pathway reciprocating tachycardia.
    Obel OA; Camm AJ
    Eur Heart J; 1998 May; 19 Suppl E():E13-24, E50-1. PubMed ID: 9717020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [High frequency current catheter ablation in treatment of supraventricular and atrioventricular tachycardia].
    Hindricks G; Kottkamp H; Willems S; Chen X; Wichter T; Haverkamp W; Yli-Mäyry S; Breithardt G; Borggrefe M
    Z Kardiol; 1995; 84 Suppl 2():103-21. PubMed ID: 7571774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Supraventricular tachycardia with wide QRS complexes during Vaughan-Williams class I anti-arrhythmic treatment. Diagnostic and therapeutic implications].
    Aouate P; Frank R; Fontaine G; Tonet J; Tageddine R; Benassar A; Turlure A; Jacquemin M; Laborde JP
    Arch Mal Coeur Vaiss; 1995 Dec; 88(12):1869-74. PubMed ID: 8729368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiarrhythmic, electrophysiologic and hemodynamic effects of ACC-9358.
    Brown BS; Calzadilla SV; Diemer MJ; Hartman JC; Reynolds RD
    J Pharmacol Exp Ther; 1987 Dec; 243(3):1225-34. PubMed ID: 3694532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Supraventricular tachycardia due to simultaneous conduction in the rapid and slow nodal pathways. Treatment by ablation of the slow pathway].
    Goutner C; Dechandol AM; Bourguet JC; Donzeau JP
    Arch Mal Coeur Vaiss; 1995 Nov; 88(11):1651-5. PubMed ID: 8746002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Current treatment of supraventricular tachycardia: drug therapy].
    Manz M; Lüderitz B
    Z Gesamte Inn Med; 1993 Sep; 48(9):430-8. PubMed ID: 8212748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Supraventricular tachycardias: mechanism, diagnosis and therapy].
    Osswald S; Buser PT; Rickenbacher P; Pfisterer M
    Schweiz Med Wochenschr; 1996 Jun; 126(22):974-85. PubMed ID: 8693318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regular supraventricular tachycardias associated with idiopathic atrial fibrillation.
    Gonzalez-Zuelgaray J; Perez A
    Am J Cardiol; 2006 Nov; 98(9):1242-4. PubMed ID: 17056338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Experience in 1,500 patients undergoing radiofrequency ablation in the treatment of tachycardias].
    Iturralde Torres P; Colín Lizalde L; Guevara Valdivia M; Rodríguez Chávez L; Kershenovich Shapiro S
    Arch Inst Cardiol Mex; 2000; 70(4):349-66. PubMed ID: 11075281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dexmedetomidine: a novel drug for the treatment of atrial and junctional tachyarrhythmias during the perioperative period for congenital cardiac surgery: a preliminary study.
    Chrysostomou C; Beerman L; Shiderly D; Berry D; Morell VO; Munoz R
    Anesth Analg; 2008 Nov; 107(5):1514-22. PubMed ID: 18931208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curing reentrant atrial arrhythmias. Targeting protected zones of slow conduction by catheter ablation.
    Lesh MD; Van Hare GF; Fitzpatrick AP; Griffin JC; Chu E
    J Electrocardiol; 1993; 26 Suppl():194-203. PubMed ID: 8189124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrophysiologic effects of intravenous E-4031, a novel class III antiarrhythmic agent, in patients with supraventricular tachyarrhythmias.
    Fujiki A; Tani M; Mizumaki K; Shimono M; Inoue H
    J Cardiovasc Pharmacol; 1994 Mar; 23(3):374-8. PubMed ID: 7515979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catheter ablation of supraventricular arrhythmias and atrial fibrillation.
    Shapira AR
    Am Fam Physician; 2009 Nov; 80(10):1089-94. PubMed ID: 19904893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The anti-arrhythmia effect and hemodynamic effects of Bonnecor in intravenous administration].
    Volkmann H; Kühnert H; Dannberg G; Küch N; Büttner A
    Z Gesamte Inn Med; 1989 Dec; 44(23):707-11. PubMed ID: 2629366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analysis of changes in repolarization for the differential diagnosis of narrow QRS supraventricular tachycardia and the site of the accessory pathway].
    Fassini G; Riva S; Della Bella P; Carbucicchio C; Tondo C
    Cardiologia; 1996 Sep; 41(9):869-75. PubMed ID: 8983843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.